Ad www.AngelOne.in
FREE Account Opening + Zero AMC Fees* + MutualFund SIP1
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Ad www.AngelOne.in
Right Issue Status: Closed [8th Aug 2023 to 17th Aug 2023]
Piramal Pharma Limited offers Right Issue size worth of Rs 1050.00 Cr. The subscription for this Rights Issue is opening from 08 Aug to 16 Aug 2023. The Face value of this Rights issue is Rs 10 per share. The Entitlement is described as 05 equity shares for every 46 fully paid-up equity shares held on the record date of 02 Aug 2023 . The right issue price for this company is fixed at Rs 81 per share.
Stay updated with us to know more about the Piramal Pharma Limited Right Issue Details 2023 including issue size, right issue entitlement, terms of payment, and more.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
| Piramal Pharma Issue Details | Values |
|---|---|
| Category | RightIssue |
| Right Issue Issue Size (Shares) | 12.96 Cr Shares |
| Right Issue Issue Size (Amount) | ₹1050.00 Cr |
| Face Value | ₹10 Per Equity Share |
| Right Issue - Issue Price | ₹81 per share |
| Right Issue Record Date | 2nd Aug 2023 |
| Right Issue Entitlement | 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date |
| Right Issue Terms of payment | The full amount of Rs. 81 for rights equity shares has to be paid on application. |
| Listing At | BSE, NSE |
| BSE Code | 543635 |
| NSE Code | PPLPHARMA |
In this section we have covered all important dates related to Piramal Pharma Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
| Right Issue Activity | Date |
|---|---|
| Right Issue Issue Open Date | 8th Aug 2023 |
| Right Issue Issue Close Date | 17th Aug 2023 |
| Basis of Allotment Finalisation Date* | 23rd Aug 2023 |
| Refunds Initiation* | 10th Aug 2023 |
| Credit of Shares to Demat Account* | 24th Aug 2023 |
| Right Issue Listing Date* | 28th Aug 2023 |
* - Tentative Dates
Zerodha Trade@20
Piramal Pharma Company was incorporated in Mumbai, Maharashtra on March 4, 2020. They are a pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. They operate under three business verticals (i) Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization (DMO); (ii) Piramal Critical Care (PCC), a complex hospital generics (CHG) business; and (iii) India consumer healthcare (CH) business, selling over-the-counter (OTC) products.
Its integrated network of facilities for CDMO operations is located across India, the UK and North America. They have obtained and maintained requisite approvals from various global regulatory agencies. they have development and manufacturing capabilities in areas such as high-potency APIs, antibody-drug conjugates (ADC), peptides, sterile injectables and hormonal products.
Its CDMO provides integrated drug discovery, development, and manufacturing services for both drug substances i.e. active pharmaceutical ingredients (APIs) and drug products i.e. formulations across the lifecycle of a molecule from discovery and clinical development to commercial launch. It has a diverse customer base of over 500 customers comprising bal innovator pharma companies, emerging biopharma companies and generic pharma companies.
Past performance and financial results of Piramal Pharma.
| Period Ended | 31 Mar 2021 | 31 Mar 2022 | 31 Mar 2023 |
| Assets | 10,899.78 | 12,797.04 | 14,522.56 |
| Revenue | 6,479.01 | 6,834.90 | 7,306.66 |
| Profit After Tax | 835.03 | 375.96 | -186.46 |
| Net Worth | 5,076.75 | 6,069.94 | 5,968.45 |
| Reserves and Surplus | 4,488.62 | 5,290.69 | 5,181.79 |
| Total Borrowing | 2,910.19 | 4,023.28 | 5,504.77 |
The table below is live update of Right Issue bidding details from NSE and BSE.
Piramal Pharma Right Issue Offer Document (Letter of Offer) >>Document
Piramal Pharma Right Issue Offer Document (Letter of Offer) >>Piramal Pharma Right Issue Red Herring Prospectus is not yet available.
Piramal Pharma Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Piramal Pharma Right Issue Online Application (Registrar & Transfer Agent) >>Piramal Pharma Right Issue RTA information is not yet available.
Last Updated on 2023-08-20T06:00:23+00:00
